- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02077907
Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition (MAM) in Children in Sierra Leone: a Cluster-randomised, Controlled Clinical Effectiveness Trial
The objective of this study is to test and compare the effectiveness and cost-effectiveness of four supplementary foods for the treatment of moderate acute malnutrition (MAM) in normal programmatic settings in Sierra Leone. Study participants will receive one of four test foods varying in energy and nutrient density as well as amounts provided.
- Super Cereal Plus (SC+) at 800 kcal/d, 215 g/d (Control group)
- Super Cereal (SC) and oil and sugar at 998 kcal/d - 200 g SC and 20 g oil and 20 g sugar, per day
- Corn-soy Blend 14 (CSB14) and oil at 978 kcal/day - 150 g CSB14 and 45 g oil, per day
- Plumpy'Sup - 500 kcal/d, 92 g/d
This will be a prospective, randomised, controlled effectiveness trial.
Aims
- (Impact) To compare the effectiveness of four supplementary foods in the treatment of moderate acute malnutrition (MAM) in normal programmatic settings in Sierra Leone.
- (Cost) To estimate the relative cost-effectiveness (marginal cost per child recovered from MAM, relative to comparison group, SC+) of implementing the feeding program using each commodity, taking into consideration costs of procurement/production and distribution
- (Process) To evaluate the determinants of effectiveness including: consumption adherence, preparation compliance, targeting/sharing of supplement, food components and preparation, adverse effects of foods, water contamination, hygiene and health behaviors, SES, food security, perceived barriers
Outcomes
Recovery from MAM
- Percent of children recovered from MAM (defined as achieving mid-upper arm circumference (MUAC) ≥ 12.5 cm by 12 weeks once)
- Percent default/non-response: children who do not recover after 12 weeks
- Percent relapse: children who become MAM again within 6 months of recovery
- Mean number of weeks to recovery
Hypothesis The children with MAM fed Super Cereal and oil and sugar, CSB14 and oil or Plumpy'Sup will have similar recovery outcomes to those children fed Super Cereal Plus.
Null: The children with MAM fed Super Cereal and oil and sugar, CSB14 and oil or Plumpy'Sup will have different recovery outcomes to those children fed Super Cereal Plus.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Beneficiary Children (Children 6 months to 59 months old)
Inclusion Criteria
- Child diagnosed with MAM and enrolled to receive a ration from a feeding site (i.e. enrolled in the SFP) Exclusion Criteria
- Children with bipedal oedema
- Children receiving food rations from another organization (e.g. USAID or UNICEF)
Beneficiary Mothers/Caretakers (Mothers/Caretakers of Children 6 months to 59 months old)
Inclusion Criteria
- Beneficiary Mother/Caretaker whose child is diagnosed with MAM and enrolled to receive a ration from a feeding site
- Beneficiary Mother/Caretaker has no age restrictions for inclusion (Note: Mothers/caretakers will be asked to participate regardless of age and consented appropriately; it is possible some mothers may be minors)
- Subject who is voluntarily willing to participate and indicates by signing (or marking with a thumbprint) the consent form.
Exclusion Criteria
• Beneficiary Mothers/Caretakers who participate in an interview, observation or FGD once for this study will not be eligible again for participation
Community Health Volunteers (CHV)/Health Development Committee Members (HDC) Inclusion Criteria
- Community Health Volunteers & Health Development Committee Members serving within the catchment area for the PHUs
- Community Health Volunteers that have been present during the study period
- Subject who is voluntarily willing to participate and indicates by signing the consent form
PPB and Clinic Staff Members Inclusion Criteria
- All staff members from Project Peanut Butter and the PHU who are directly involved in the feeding program
- Subject who is voluntarily willing to participate and indicates by signing the consent form Exclusion Criteria
- Staff members who joined too recently to have experience of the program change (new commodities)
Village Elders/Headmen Inclusion Criteria
- Village elder/headmen in study commune
- Subject who is voluntarily willing to participate and indicates by signing the consent form Exclusion Criteria
- Village elder/headmen whose community is not involved in the feeding program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Super Cereal Plus (SC+)
800 kcal/d, 215 g/d Current protocol for treating MAM is supplemental food distribution, often providing a fortified blended food (FBF) that requires cooking. In Sierra Leone, their FBF standard is Super Cereal Plus. |
|
Experimental: Super Cereal (SC) and oil and sugar
200 g SC and 20 g fortified oil and 15 g sugar, per day Fortified blended food (FBF) Fortified Oil with Vitamins A & D |
|
Experimental: Corn Soy Blend 14 (CSB14) and fortified oil
978 kcal/day - 150 g CSB14 and 45 g oil, per day Fortified blended food (FBF) Fortified Oil with Vitamins A & D |
|
Experimental: Plumpy'Sup
500 kcal/d, 92 g/d Ready-to-Use Supplementary Food (RUSF) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recovery from MAM
Time Frame: 12 weeks
|
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Growth rates
Time Frame: 12 weeks
|
Subjects will return to clinic every 2 weeks until MUAC of 12.5 cm is reached or until 12 weeks has elapsed.
Follow-up recovery will then be measured at 6 months.
At each clinic visit growth will be measured.
|
12 weeks
|
Duration of treatment
Time Frame: 12 weeks
|
Subjects will return to clinic every 2 weeks until MUAC of 12.5 cm is reached or until 12 weeks has elapsed.
Follow-up recovery will then be measured at 6 months.
Time to achieve MUAC of 12.5 cm will be documented.
|
12 weeks
|
Cost estimates for participation
Time Frame: 12 weeks
|
Average cost of treatment will be measured per participant, this includes intervention costs and any medical costs needed by participants.
The study costs no money to participants.
|
12 weeks
|
Default reason
Time Frame: 12 weeks
|
If a child defaults, then the reason will be an outcome measure.
Reasons to default include loss to follow-up (the child will be attempted to be contacted 3 times prior to being considered lost), death, or he/she enters into the inpatient clinic.
|
12 weeks
|
Change in recovery status after 12 weeks
Time Frame: 6 months
|
Any changes in recovery will be measured at 6 months at follow-up visits
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Relative cost-effectiveness
Time Frame: 12 weeks
|
To estimate the relative cost-effectiveness (marginal cost per child recovered from MAM, relative to comparison group, SC+) of implementing the feeding program using each commodity, taking into consideration costs of procurement/production and distribution
|
12 weeks
|
Determinants of effectiveness
Time Frame: 12 weeks
|
To evaluate the determinants of effectiveness including: consumption adherence, preparation compliance, targeting/sharing of supplement, food components and preparation, adverse effects of foods, hygiene and health behaviors, SES, food security, perceived barriers
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Beatrice Rogers, PhD, Tufts University, Friedman School of Nutrition
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AID-016-Sierra Leone
- USAID (Other Grant/Funding Number: GPO-A-00-05-00022-00;(W0118))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Moderate Acute Malnutrition (MAM)
-
Helen Keller InternationalUniversity of California, Davis; United Nations World Food Programme (WFP); U... and other collaboratorsCompletedModerate Acute Malnutrition (MAM)Mali
-
PepsiCo Global R&DCompletedModerate Acute Malnutrition (MAM)Mexico
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
Tufts UniversityWashington University School of Medicine; United States Agency for International... and other collaboratorsCompletedModerate Acute MalnutritionSierra Leone
-
International Centre for Diarrhoeal Disease Research...Suzuhiro Kamaboko Co., Ltd.,JapanCompletedModerate Acute MalnutritionBangladesh
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineNot yet recruitingModerate Acute MalnutritionBangladesh
-
International Centre for Diarrhoeal Disease Research...University Ghent; United Nations World Food Programme (WFP); Action Contre la...Not yet recruitingModerate Acute MalnutritionBangladesh
-
PepsiCo Global R&DCompleted
-
Institute of Tropical Medicine, BelgiumUniversity Ghent; Institut de Recherche en Sciences de la Sante, Burkina Faso; Ministry of Health, Burkina FasoCompletedModerate Acute MalnutritionBurkina Faso
Clinical Trials on Plumpy Sup
-
Institut de Recherche pour le DeveloppementUnited Nations World Food Programme (WFP); UNICEF; Sidaction; Global FundCompletedHIV/AIDS | Malnutrition
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingThyroid Cancer | Lymph Node Metastases | Positron-Emission TomographyChina
-
International Centre for Diarrhoeal Disease Research...Washington University School of Medicine; University of Virginia; International...CompletedSevere Acute MalnutritionBangladesh
-
France BroilletSwiss Tropical & Public Health InstituteCompleted
-
University of British ColumbiaChildren's & Women's Health Centre of British ColumbiaTerminated
-
Action Contre la FaimUniversity GhentCompletedChild | MalnutritionChad
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
University of British ColumbiaChildren's & Women's Health Centre of British ColumbiaWithdrawnBirth Related Brachial Plexus Injury | Obstetrical Brachial Plexus Palsy
-
University of PittsburghCompleted
-
Washington University School of MedicineCompleted